Home
Clinical Resources Search
PQI: Neratinib (Nerlynx®) Diarrhea Management

Neratinib (Nerlynx®) Diarrhea Management

Last Updated: October 10, 2023

By: Eric Dallara, RPh

About this PQI

Diarrhea is the main toxicity of neratinib treatment occurring in 95% of patients in the ExteNET trial on the neratinib arm in which antidiarrheal prophylaxis was not protocol specified. 1 Various prevention and treatment strategies for diarrhea have been studied and will be discussed in this document.

More About This PQI

PQI in Action Articles:

neratinib_nerlynx_diarrhea pdf 1MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Neratinib (Nerlynx®) Diarrhea Management

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E12: “We Won the Battle, Now Let’s Paddle”

S9 E11: Honoring Veterans Through Early Cancer Detection

S9 E10: Advancing Clinical Research

S9 E9: The Realities of Ethics in Oncology

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S9 E12: “We Won the Battle, Now Let’s Paddle”

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

Etoposide

S9 E6: Healing Through Sound: A Breast Cancer Journey

Understanding Diarrhea During Cancer Treatment

PQI: Sacituzumab govitecan-hziy (Trodelvy®): Prophylaxis and Management of Adverse Events

PQI: Oncolytic Induced Diarrhea

PQI: Telotristat Ethyl (Xermelo®) for the Management of Carcinoid Syndrome Diarrhea

PQI: Tivozanib (Fotivda) for Relapsed or Refractory Advanced Renal Cell Carcinoma

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

PQI: Temozolomide (Temodar®) for Glioblastoma Multiforme

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Treatment Support Kit: Neratinib

Neratinib

Treatment Support Kit: Neratinib

Neratinib

PQI in Action: Neratinib (Nerlynx) Diarrhea Management

S9 E12: “We Won the Battle, Now Let’s Paddle”

Vimseltinib

Revumenib

Imetelstat